GRIPonMASH Reaches Major Milestone: Over 5,000 Participants Enrolled and 25,000+ Samples Collected Across Europe
European study reaches halfway point of ambitious goal of screening 10,000 individuals at risk of MASLD Utrecht, The Netherlands, May 19, 2026: The GRIPonMASH project has reached a significant milestone in its mission to improve early detection and understanding of metabolic dysfunction-associated steatotic liver disease (MASLD). More than 5,000 participants, representing over 50% of the […]
Why Liver Screening Needs a Seat in Everyday Healthcare
A Silent Condition with Growing Impact Liver disease linked to metabolic dysfunction is no longer a niche concern. It is increasingly recognised as one of the most common chronic conditions worldwide, yet it remains underdiagnosed and often overlooked in routine care. A key reason for this is its silent nature. In its early stages, excess […]
